A new approach to deriving community exposure guidelines from "no-observed-adverse-effect levels"
Regul Toxicol Pharmacol
.
1990 Jun;11(3):314-30.
doi: 10.1016/0273-2300(90)90030-f.
Authors
S C Lewis
1
,
J R Lynch
,
A I Nikiforov
Affiliation
1
Exxon Biomedical Sciences, Inc., East Millstone, New Jersey 08875-2350.
PMID:
2196639
DOI:
10.1016/0273-2300(90)90030-f
No abstract available
Publication types
Review
MeSH terms
Animals
Environmental Pollution / adverse effects*
Environmental Pollution / legislation & jurisprudence
Humans
Risk Factors
United States